AMPKα2 deletion exacerbates neointima formation by upregulating Skp2 in vascular smooth muscle cells

Ping Song1, Shuangxi Wang, Chaoyong He

  • 1Section of Molecular Medicine, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, 73104, USA. psong@ouhsc.edu

Circulation Research
|October 8, 2011
PubMed
Abstract

Insights

Adenosine monophosphate-activated protein kinase alpha 2 (AMPKα2) deletion promotes vascular neointima formation by increasing smooth muscle cell proliferation. This occurs via reduced p27(Kip1) and increased Skp2, leading to neointimal hyperplasia after injury.

Area of Science:

  • Vascular biology and cell signaling.
  • Cardiovascular research.
  • Molecular mechanisms of hyperplasia.

Background:

  • Adenosine monophosphate-activated protein kinase (AMPK) is a key metabolic and redox sensor.
  • AMPK generally suppresses cell proliferation in both normal and cancerous cells.
  • The role of AMPKα in vascular neointima formation following injury remains unclear.

Purpose of the Study:

  • To investigate the specific roles of AMPKα isoforms (AMPKα1 and AMPKα2) in vascular neointima hyperplasia.
  • To elucidate the molecular mechanisms by which AMPKα influences neointima development.
  • To determine if AMPKα affects vascular smooth muscle cell (VSMC) proliferation and arterial remodeling.

Main Methods:

  • Comparative analysis of VSMC proliferation and neointimal hyperplasia in wild-type, AMPKα1(-/-), and AMPKα2(-/-) mice.
  • Assessment of key protein levels including p27(Kip1) and S-phase kinase-associated protein 2 (Skp2).
  • Investigation of the involvement of p52 nuclear factor kappa B (NF-κB)-2 and ubiquitination pathways.
  • Pharmacological and genetic inhibition of AMPK in human VSMCs.

Main Results:

  • AMPKα2 knockout (KO) VSMCs showed significantly increased proliferation compared to wild-type or AMPKα1 KO VSMCs.
  • AMPKα2 deficiency led to decreased p27(Kip1) and increased Skp2 levels, mediated by p52 NF-κB-2 activation.
  • Pharmacological or genetic inhibition of AMPK in human VSMCs mimicked these effects on p27(Kip1) and Skp2.
  • Silencing Skp2 reversed the increased proliferation and normalized p27(Kip1) levels in AMPK-inhibited VSMCs.
  • Neointima formation after wire injury was significantly elevated in AMPKα2(-/-) mice but not in AMPKα1(-/-) mice.

Conclusions:

  • AMPKα2 plays a critical role in suppressing vascular neointima formation.
  • Deletion of AMPKα2 exacerbates neointimal hyperplasia by promoting VSMC proliferation.
  • The mechanism involves p52-Skp2-mediated ubiquitination and degradation of the cyclin-dependent kinase inhibitor p27(Kip1).

Related Concept Videos

cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...